Dec 21 (Reuters) - Oxford University and AstraZeneca Plc
have begun work to produce an Omicron-targeted version
of their coronavirus vaccine, the Financial Times reported https://www.ft.com/content/e61faf47-d563-4a87-8f0c-dcf7b8b28b43
on Tuesday.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by Leslie
Adler)
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more